University of Milan, 20 July 2015
Starting from the Rare Cancers Europe consensus position paper on the methodology of clinical studies in rare cancers, the goal of this event was to inform and educate patient advocates about the Rare Cancers Europe recommendations, improve the awareness around the related challenges, and hopefully find fertile ground for implementation at a national level.
Meeting resources
You can now download presentations from the meeting:
-
Welcome from Rare Cancers Europe
Paolo G. Casali
Rare Cancers Europe
-
What is needed for better decision-making?
Paolo G. Casali
Rare Cancers Europe
-
The principles of frequentist and Bayesian medical statistics
Paolo Bruzzi
Italian National Cancer Research Institute
-
Surrogate Endpoints in rare cancers
Paolo Bruzzi
Italian National Cancer Research Institute
-
Study designs in rare cancer
Saskia Litière
EORTC
-
Organizational aspects of clinical research in rare cancers
Anastassia Negrouk
EORTC
-
Empowering patient’s decision-making autonomy
Gabriella Pravettoni
University of Milan